Trial Profile
A Phase II Study of Panitumumab 5-Fluorouracil and Oxaliplatin in combination with pelvic radiotherapy as treatment of resectable and locally advanced rectal cancer (StarPan Study STAR 02).
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 31 Oct 2011
Price :
$35
*
At a glance
- Drugs Panitumumab (Primary) ; Fluorouracil; Oxaliplatin
- Indications Rectal cancer
- Focus Therapeutic Use
- Acronyms StarPan-STAR 02
- 26 Jul 2011 New trial record